Moderna, Inc.

MRNA · NasdaqGS

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▼ 0.0% below current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

–

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders7.3%

Institutions80.6%

Public / Other

Income Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	$1.94B	$3.24B	$6.85B	$19.26B	$18.47B	$803.39M	$60.21M	$135.07M
The direct costs of producing what was sold — raw materials, manufacturing, direct labor.	$868.00M	$1.46B	$4.69B	$5.42B	$2.62B	$7.93M	–	–
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	-$3.07B	-$3.94B	-$4.24B	$9.42B	$13.30B	-$763.14M	-$545.72M	-$413.27M
Operating income as a percentage of revenue.	-158.1%	-121.9%	-61.9%	48.9%	72.0%	-95.0%	-906.4%	-306.0%
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	-$2.82B	-$3.56B	-$4.71B	$8.36B	$12.20B	-$747.06M	-$514.00M	-$384.70M
Net income divided by the number of shares outstanding — profit attributable to each share.	$-7.26	$-9.28	$-12.33	$21.26	$30.31	$-1.96	$-1.00	$-4.00
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$-7.26	$-9.28	$-12.33	$20.12	$28.29	–	–	–

Balance Sheet

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$2.60B	$1.93B	$2.91B	$3.21B	$6.85B	$2.62B	$235.88M	$658.36M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$12.34B	$14.14B	$18.43B	$25.86B	$24.67B	–	$1.59B	$1.96B
All of the company's interest-bearing borrowings, short and long term combined.	$590.00M	–	–	–	–	–	–	–
Everything the company owes — debt, unpaid bills, and other obligations.	$3.69B	$3.24B	$4.57B	$6.74B	$10.52B	–	$414.61M	$431.91M
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$8.65B	$10.90B	$13.85B	$19.12B	$14.14B	–	$1.17B	$1.53B

Cash Flow Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	-$1.87B	-$3.00B	-$3.12B	$4.98B	$13.62B	$2.03B	-$458.97M	-$330.87M
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$192.00M	$1.05B	$707.00M	$400.00M	$284.00M	$67.45M	$31.55M	$105.77M
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	-$2.06B	-$4.05B	-$3.83B	$4.58B	$13.34B	$1.96B	-$490.52M	-$436.63M

	You	Peer avg
P/E	–	25.2
Revenue Growth	+2.1%	+12.2%
ROE	-39.0%	27.1%

Moderna, Inc.

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Income Statement

Balance Sheet

Cash Flow Statement

Peer Comparison